• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

旧的去,新的来:机器学习在事件时间生物医学研究中的应用。

In with the old, in with the new: machine learning for time to event biomedical research.

机构信息

Advanced Computing for Health Sciences Group, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.

Department of Biomedical Informatics, Vanderbilt University, Nashville, Tennessee, USA.

出版信息

J Am Med Inform Assoc. 2022 Sep 12;29(10):1737-1743. doi: 10.1093/jamia/ocac106.

DOI:10.1093/jamia/ocac106
PMID:35920306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9471708/
Abstract

The predictive modeling literature for biomedical applications is dominated by biostatistical methods for survival analysis, and more recently some out of the box machine learning approaches. In this article, we show a presentation of a machine learning method appropriate for time-to-event modeling in the area of prostate cancer long-term disease progression. Using XGBoost adapted to long-term disease progression, we developed a predictive model for 118 788 patients with localized prostate cancer at diagnosis from the Department of Veterans Affairs (VA). Our model accounted for patient censoring. Harrell's c-index for our model using only features available at the time of diagnosis was 0.757 95% confidence interval [0.756, 0.757]. Our results show that machine learning methods like XGBoost can be adapted to use accelerated failure time (AFT) with censoring to model long-term risk of disease progression. The long median survival justifies and requires censoring. Overall, we show that an existing machine learning approach can be used for AFT outcome modeling in prostate cancer, and more generally for other chronic diseases with long observation times.

摘要

生物医学应用的预测建模文献主要由生存分析的生物统计学方法主导,最近也出现了一些新颖的机器学习方法。在本文中,我们展示了一种适用于前列腺癌长期疾病进展领域的时间事件建模的机器学习方法。我们使用 XGBoost 对长期疾病进展进行了调整,为来自退伍军人事务部(VA)的 118788 名局部前列腺癌患者建立了一个预测模型。我们的模型考虑了患者的删失。我们的模型仅使用诊断时可用的特征,Harrell 的 c 指数为 0.757(95%置信区间为 0.756,0.757)。我们的结果表明,像 XGBoost 这样的机器学习方法可以适应使用带有删失的加速失效时间(AFT)来对疾病进展的长期风险进行建模。较长的中位生存期证明了且需要进行删失。总的来说,我们表明现有的机器学习方法可以用于前列腺癌的 AFT 结果建模,更普遍地用于其他具有较长观察时间的慢性疾病。

相似文献

1
In with the old, in with the new: machine learning for time to event biomedical research.旧的去,新的来:机器学习在事件时间生物医学研究中的应用。
J Am Med Inform Assoc. 2022 Sep 12;29(10):1737-1743. doi: 10.1093/jamia/ocac106.
2
Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study.统计和机器学习模型在乳腺癌预后预测中的开发和内外验证:队列研究。
BMJ. 2023 May 10;381:e073800. doi: 10.1136/bmj-2022-073800.
3
Survival prediction models: an introduction to discrete-time modeling.生存预测模型:离散时间建模简介。
BMC Med Res Methodol. 2022 Jul 26;22(1):207. doi: 10.1186/s12874-022-01679-6.
4
Machine Learning Approaches for Early Prostate Cancer Prediction Based on Healthcare Utilization Patterns.基于医疗利用模式的早期前列腺癌预测的机器学习方法。
Stud Health Technol Inform. 2022 Jan 14;289:65-68. doi: 10.3233/SHTI210860.
5
Identifying prostate cancer and its clinical risk in asymptomatic men using machine learning of high dimensional peripheral blood flow cytometric natural killer cell subset phenotyping data.利用高维外周血细胞流式自然杀伤细胞亚群表型数据的机器学习识别无症状男性中的前列腺癌及其临床风险。
Elife. 2020 Jul 28;9:e50936. doi: 10.7554/eLife.50936.
6
Machine-learning Algorithm-based Risk Prediction and Screening-detected Prostate Cancer in A Benign Prostate Hyperplasia Cohort.基于机器学习算法的风险预测和筛查检测在良性前列腺增生队列中的前列腺癌。
Anticancer Res. 2024 Apr;44(4):1683-1693. doi: 10.21873/anticanres.16967.
7
Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database.应用新型机器学习框架,利用监测、流行病学和最终结果(SEER)数据库预测男性非转移性前列腺癌特异性死亡率。
Lancet Digit Health. 2021 Mar;3(3):e158-e165. doi: 10.1016/S2589-7500(20)30314-9. Epub 2021 Feb 3.
8
Development, comparison, and validation of four intelligent, practical machine learning models for patients with prostate-specific antigen in the gray zone.针对前列腺特异性抗原处于灰色区域的患者,开发、比较并验证四种智能实用的机器学习模型。
Front Oncol. 2023 Jun 8;13:1157384. doi: 10.3389/fonc.2023.1157384. eCollection 2023.
9
Development and Validation of a Machine Learning Model for Bone Metastasis in Prostate Cancer: Based on Inflammatory and Nutritional Indicators.基于炎症和营养指标的前列腺癌骨转移机器学习模型的开发与验证
Urology. 2024 Aug;190:63-70. doi: 10.1016/j.urology.2024.05.027. Epub 2024 May 31.
10
Machine learning-based prediction of 1-year mortality for acute coronary syndrome.基于机器学习的急性冠状动脉综合征 1 年死亡率预测。
J Cardiol. 2022 Mar;79(3):342-351. doi: 10.1016/j.jjcc.2021.11.006. Epub 2021 Nov 29.

引用本文的文献

1
A landmark federal interagency collaboration to promote data science in health care: Million Veteran Program-Computational Health Analytics for Medical Precision to Improve Outcomes Now.一项具有里程碑意义的联邦跨部门合作,旨在促进医疗保健领域的数据科学发展:百万退伍军人计划——用于医疗精准性以改善当前治疗效果的计算健康分析。
JAMIA Open. 2024 Nov 6;7(4):ooae126. doi: 10.1093/jamiaopen/ooae126. eCollection 2024 Dec.
2
Deep Learning on Multimodal Chemical and Whole Slide Imaging Data for Predicting Prostate Cancer Directly from Tissue Images.深度学习多模态化学和全玻片成像数据,直接从组织图像预测前列腺癌。
J Am Soc Mass Spectrom. 2023 Feb 1;34(2):227-235. doi: 10.1021/jasms.2c00254. Epub 2023 Jan 10.

本文引用的文献

1
Development and Validation of an Interpretable Artificial Intelligence Model to Predict 10-Year Prostate Cancer Mortality.用于预测10年前列腺癌死亡率的可解释人工智能模型的开发与验证
Cancers (Basel). 2021 Jun 19;13(12):3064. doi: 10.3390/cancers13123064.
2
Adversarial Time-to-Event Modeling.对抗性生存时间建模
Proc Mach Learn Res. 2018 Jul;80:735-744.
3
How Machine Learning Will Transform Biomedicine.机器学习如何改变生物医学。
Cell. 2020 Apr 2;181(1):92-101. doi: 10.1016/j.cell.2020.03.022.
4
Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model.非转移性前列腺癌诊断时的个体预后:PREDICT Prostate 多变量模型的建立和外部验证。
PLoS Med. 2019 Mar 12;16(3):e1002758. doi: 10.1371/journal.pmed.1002758. eCollection 2019 Mar.
5
DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network.DeepSurv:使用 Cox 比例风险深度神经网络的个性化治疗推荐系统。
BMC Med Res Methodol. 2018 Feb 26;18(1):24. doi: 10.1186/s12874-018-0482-1.
6
The MIMIC Code Repository: enabling reproducibility in critical care research.MIMIC 代码库:实现重症监护研究的可重复性。
J Am Med Inform Assoc. 2018 Jan 1;25(1):32-39. doi: 10.1093/jamia/ocx084.
7
Cancer Incidence Among Patients of the U.S. Veterans Affairs Health Care System: 2010 Update.美国退伍军人事务部医疗保健系统患者中的癌症发病率:2010年更新
Mil Med. 2017 Jul;182(7):e1883-e1891. doi: 10.7205/MILMED-D-16-00371.
8
Follow-up of Prostatectomy versus Observation for Early Prostate Cancer.前列腺癌早期行前列腺切除术与观察治疗的随访研究。
N Engl J Med. 2017 Jul 13;377(2):132-142. doi: 10.1056/NEJMoa1615869.
9
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.局限性前列腺癌监测、手术或放疗 10 年后的结果。
N Engl J Med. 2016 Oct 13;375(15):1415-1424. doi: 10.1056/NEJMoa1606220. Epub 2016 Sep 14.
10
MIMIC-III, a freely accessible critical care database.MIMIC-III,一个免费获取的重症监护数据库。
Sci Data. 2016 May 24;3:160035. doi: 10.1038/sdata.2016.35.